Want More Education?
Delve deeper into the science behind skin care with —Skin Inc. Video Education!
Most Popular in:
Regulations
New in Regulations (page 8 of 13)
Congress Presented with Psoriasis Legislation
The Psoriasis and Psoriatic Arthritis Research Cure and Care Act (PPARCCA) of 2009 (H.R. 930) has been reintroduced in the U.S. House of Representatives.
Justifying Skin Care Claims
By: Imogen Matthews
Product claims sell skin care, yet increasingly savvy consumers are questioning whether these claims really stand up to scrutiny. What are the challenges facing beauty brands in making claims in various markets?
Natural vs. Organic
By: Carl Thornfeldt, MD
Knowing the difference between natural and organic can help you determine what's best for your clients.
FDA Issues Health Warning on Use of Topical Anesthetics
Ignited by global growth in the use of topical anesthetics for cosmetic procedures, the U.S. Food and Drug Administration (FDA) has issued a health warning after a study concluded that the drug lidocaine carries risks.
Two Join the PCPC's Cosmetic Ingredients Review Expert Panel
The Personal Care Products Council has announced the appointment of two new members to the Cosmetic Ingredients Review (CIR) Expert Panel.
Green Aspects of the Beauty Industry Strengthened in 2008
The year has seen the strengthening of all things green in both the political and public consciousness. However, how is the cosmetics industry reacting to these shifting ideals and principles?
Panel Urges FDA to Revise Sunscreen Standards
A panel organized by the Citizens for Sun Protection recently convened to put pressure on the FDA to adopt new sunscreen standards.
Potential Issues That May Affect Spa Industry
PBA's director of government affairs outlines upcoming congressional issues that will affect the spa industry.
FDA Investigates Consumer Knowledge of Dermal Fillers' Safety
Consumers may not be fully informed of the potential dangers of wrinkle injections, according to an FDA panel.
Products Incorrectly Labeled as Cosmetics Scrutinized by the FDA
The U.S. Food and Drug Administration (FDA) has published fresh warning letters to tackle the problem of companies that incorrectly market their products as cosmetics.